Marjolijn N Lub-de Hooge

13PUBLICATIONS
52CO-AUTHORS
Medical physicsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsClinical pharmacy and pharmacy practiceMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 08, 2026
Tri-specific Humabody CB307 Targeting CD137, Prostate-specific Membrane Antigen, and Human Serum Albumin Whole-body Biodistribution Measured with 89Zr-CB307 PET.

|Nov 25, 2025
Whole-body CD8+ T-cell PET imaging in patients with large B-cell lymphoma before and during CD19-directed CAR T-cell therapy: a phase 2 study.

Janneke W de Boer, Kylie Keijzer, Jaap A van Doesum

|Oct 29, 2025
Development of Clinical-Grade Durvalumab-680LT and Nivolumab-800CW for Multispectral Fluorescent Imaging of the PD-1/PD-L1 Axis of the Immune Checkpoint Pathway.

Henrik K Huizinga, Wouter T R Hooghiemstra, Matthijs D Linssen

|Aug 28, 2025
Extemporaneous Compounding, Pharmacy Preparations and Related Product Care in the Netherlands.

Herman J Woerdenbag, Boy van Basten, Christien Oussoren

|Sep 26, 2024
Molecular imaging supports the development of multispecific cancer antibodies.

Claudia A J van Winkel, Frank R Pierik, Adrienne H Brouwers

|Sep 26, 2024
Facts and Hopes for PET Imaging-Derived Immunotherapy Biomarkers.

Derk Jan A de Groot, Marjolijn N Lub-de Hooge, Tom van Meerten

Pageof 3

Frequent Collaborators

7 joint publications

Elisabeth Ge de Vries

6 joint publications

Adrienne H Brouwers

3 joint publications

Frank R Pierik

3 joint publications

Joyce van Sluis